Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5842307 | Life Sciences | 2013 | 7 Pages |
Abstract
We demonstrate the relationship between EZH2 and multidrug-resistance in hepatic cancer for the first time. EZH2 may become a new target for gene therapy to reverse multidrug-resistance in hepatic cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yi Zhang, Guangpu Liu, Changwei Lin, Guoqing Liao, Bo Tang,